Versigent (NYSE:VGNT – Get Free Report) announced its earnings results on Wednesday. The company reported $1.91 earnings per share for the quarter, beating the consensus estimate of $1.79 by $0.12, Zacks reports. The firm had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.42 billion.
Here are the key takeaways from Versigent’s conference call:
- Versigent reported 7% sales growth, 11% higher adjusted EBITDA, and 40 basis points of margin expansion; adjusted sales grew about 1% despite global automotive production declining approximately 2%. This marked its sixth consecutive quarter of growth over market.
- The company raised its 2026 free-cash-flow guidance to $275 million–$325 million, citing stronger year-to-date performance and the timing of some initiatives. The higher sales outlook reflects increased copper pass-throughs, while the adjusted EBITDA midpoint remains unchanged at $990 million.
- Versigent reported more than 115 program launches so far this year, with over 99% quality and on-time delivery, and secured $7.5 billion in year-to-date bookings. Management said the launches and awards demonstrate its ability to execute complex programs and support future growth.
- EMEA adjusted sales fell 8% amid weak demand, lower vehicle production, and program roll-offs. Elevated fourth-quarter launch activity and the lag in copper-cost recovery may also pressure sequential margins; management cautioned that third-quarter margins are not a new run rate.
- Adjacent markets such as battery energy storage, power generation, and robotics are generating early wins, but many programs remain in development or small-scale production. Management said these opportunities are not expected to contribute meaningfully to its current outlook.
Versigent Stock Down 3.3%
Shares of VGNT stock traded down $1.38 during mid-day trading on Thursday, hitting $40.59. The stock had a trading volume of 448,094 shares, compared to its average volume of 1,521,283. Versigent has a 12-month low of $26.34 and a 12-month high of $50.88. The firm has a market capitalization of $2.87 billion and a P/E ratio of 21.21. The firm’s 50-day moving average is $45.08 and its two-hundred day moving average is $42.71. The company has a debt-to-equity ratio of 7.29, a current ratio of 1.40 and a quick ratio of 1.09.
Versigent Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Friday, December 4th will be given a dividend of $0.13 per share. The ex-dividend date of this dividend is Friday, December 4th. This represents a $0.52 dividend on an annualized basis and a yield of 1.3%.
Insider Activity at Versigent
In related news, Director Kevin Clark sold 74,130 shares of Versigent stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the completion of the sale, the director directly owned 124,849 shares in the company, valued at $5,701,853.83. The trade was a 37.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders sold a total of 220,000 shares of company stock worth $10,065,848 in the last 90 days.
More Versigent News
Here are the key news stories impacting Versigent this week:
- Positive Sentiment: Q3 revenue was $2.45 billion, up 7.2% year over year, and adjusted EPS of $1.91 beat the $1.79 consensus estimate. Revenue also topped forecasts of $2.42 billion. Versigent Reports Third Quarter 2026 Results
- Positive Sentiment: The company declared a quarterly dividend of $0.13 per share, payable December 17, equivalent to an annualized yield of about 1.2%. Dividend announcement
- Neutral Sentiment: CFO Doug Ostermann is scheduled to speak at the RBC Capital Markets Global Industrials Conference on November 17; the announcement did not include new financial guidance. CFO to Participate in RBC Conference
- Negative Sentiment: Despite the reported sales increase, adjusted net sales growth was approximately 1% year over year. That subdued underlying growth, alongside market pressures discussed on the earnings call, tempers the headline beat and may help explain the stock’s recent weakness. The company reported GAAP diluted EPS of $1.41, below its adjusted EPS figure. Versigent Earnings Call Shows Growth Despite Market Pressures
Analysts Set New Price Targets
VGNT has been the topic of a number of analyst reports. BNP Paribas Exane reaffirmed an “outperform” rating and set a $54.00 target price (down from $55.00) on shares of Versigent in a research note on Thursday. Evercore restated an “outperform” rating and set a $65.00 price objective on shares of Versigent in a report on Monday, August 10th. Zacks Research downgraded Versigent from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Weiss Ratings upgraded Versigent from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Finally, Fox Advisors downgraded Versigent from an “overweight” rating to an “equal weight” rating in a research report on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $55.08.
Get Our Latest Research Report on Versigent
About Versigent
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Read More
- Five stocks we like better than Versigent
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
- South Korea’s Chip Exports Are Soaring—So Why Is This ETF Down 20%?
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
